期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

阿司匹林与冠心病研究进展 被引量：15

原文传递
导出
摘要 血小板因素在冠心病发病机制中起重要作用。阿司匹林对血小板活化有明显抑制效果。本文就血小板与冠心病的关系及阿司匹林在冠心病治疗中的作用作一综述。
作者 乔华 何胜虎
机构地区 扬州大学临床医学院苏北人民医院心内科
出处 《中华实用诊断与治疗杂志》 2010年第9期837-839,共3页 Journal of Chinese Practical Diagnosis and Therapy
关键词 冠心病 血小板 阿司匹林
分类号 R541.4 [医药卫生—心血管疾病]
  • 相关文献

参考文献21

  • 1Kner N, Marah J D. Pathobiology of atheroaclerosis: a brief review[J]. Semin Thromb Hernast, 2004,30 (6) : 665-672.
  • 2Reiner Zeachi-reiner E. New information on the pathophysiology of atherosclerosis of atherosclerosis[J]. Lijec Vjesn,2001,123(1- 2) :26-31.
  • 3Bolli R, Shinmura K, Tang X L, et al. Discovery of a new function of cyclooxygenasc ( COX )-2: COX 2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning [J]. Cardiovasc Res,2002,55(3) :506- 519.
  • 4Loll P J, Picot D, Garavito R M, et al. The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase[J]. Nat Struct Biol,1995,2(8):637- 643.
  • 5Ross R. Atherosclerosis: an inflammatory disease[J]. N Eng J Med,1999,340(2) :115-126.
  • 6Yin M J, Yamamoto Y, Gaynor R B. The anti-inflammatory agents aspirin and salieylate inhibit the activity of 1 (kappa) B kinase beta[J].Nature,1998,396(6706):77-80.
  • 7Shi X, Ding M, Dong Z, et ah Antioxidant properties of aspirin: characterization of the ability to inhibit silica induced lipid peroxidation, DNA damage, NF KB activation, and TNF alpha production[J].Mol Cell Biochem,1999,199(1- 2): 93-102.
  • 8Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction: Isls 2. Isis-2 (Second International Study of Infarct Survival) Collaborative Group[J].Lancet, 1988, 2 (8607) :349-360.
  • 9Grosscr T, Fries S, FitzGerald G A. Biological basis forthecardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities[J]. J Clin Invest, 2006,116 (1) : 4- 15.
  • 10Antithrombotic Trialists' CollaBoration. Collaborative metaanalysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high riskpatients[J].BMJ,2002,324(7329):71-86.

二级参考文献16

共引文献31

同被引文献93

  • 1李为民.2009冠心病研究进展回顾[J].中国医学前沿杂志（电子版）,2010,2(1):36-42. 被引量：8
  • 2莫晓燕,黄海霞,洪喻,耿涛,张振强,杜晓阳.赤芍总苷对培养乳鼠心肌细胞损伤的抗氧化作用[J].中国药理学通报,2004,20(10):1119-1121. 被引量：22
  • 3Steven E. Nissen,Stephen J. Nicholls,Ilks Sipahi,Peter Libby,Joel S. Raichlen,Christie M. Ballantyne,Jean Davignon,Raimund Erbel,Jean Charles Fruchart,Jean-Claude Tardif,Paul Schoenhagen,Tim Crowe,Valerie Cain,Kathy Wolski,Marlene Coormastic,E. Murat Tuzcu,仝其广（译）,王淑敏（译）,胡大一（校）.极高强度他汀治疗对冠状动脉粥样硬化消退的影响——ASTEROID试验[J].美国医学会杂志（中文版）,2006,25(4):215-223. 被引量：346
  • 4李端.药理学[M].北京:人民卫生出版社,2008:295.
  • 5王晓岩,杜凤和.冠心病患者服用阿司匹林前后血小板功能及代谢产物的变化[J].山东医药,2007,47(19):16-18. 被引量：3
  • 6Bhatt D, Topoi E J. Scientific and therapeutic advanccs in antiplatelet therapy[J]. Nature Rev,2003,2(1):15-28.
  • 7Michelson A D. Platelet function testing in cardiovascular diseases[J]. Circulation,2004,110(9) :e489-e493.
  • 8Gum P A, Kottke-Marchant K, Poggio E D, et al. Profile and prevalence of aspirin resistance in patients with cardiovascular disease[J]. Am J Cardiol,2001,88(3) :230-235.
  • 9George K R, Stephanie J B, W Scott B. Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta analysis[J]. BMJ,2008,336(7637) : 195-198.
  • 10Tantry U S, Bliden K P, Gurbel P A. Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using araehidonie acid stimulation[J]. Am Coil Cardiol, 2005, 46(9) :1705-1709.

引证文献15

二级引证文献109

中华实用诊断与治疗杂志
2010年 第9期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部